NAD+ is a molecule that plays a vital role in many cellular processes, such as energy metabolism, DNA repair, gene expression, and cell signaling. It is also a key component of the sirtuin enzymes, which are involved in regulating lifespan and healthspan in various organisms (Imai and Guarente, 2014). NAD+ levels decline with age and in many chronic diseases, such as diabetes, obesity, neurodegeneration, and cancer (Verdin, 2015). This decline may contribute to the development and progression of these conditions, as well as to the general decline in physiological function that occurs with aging. Therefore, boosting NAD+ levels may have beneficial effects on health and aging.
One of the main ways to increase NAD+ levels is through dietary supplementation with NAD+ precursors or intermediates. These are compounds that can be converted into NAD+ in the body through different pathways. The most well-known and widely used NAD+ precursors are nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), which are both forms of vitamin B3 (Bogan and Brenner, 2008). Other NAD+ intermediates include nicotinamide (NAM), nicotinic acid (NA), and tryptophan (TRP) (Yoshino et al., 2018).
There is growing evidence from animal and human studies that supplementation with NAD+ precursors or intermediates can increase NAD+ levels in various tissues and organs, and improve various aspects of health and aging, such as glucose metabolism, mitochondrial function, inflammation, oxidative stress, DNA repair, cognitive function, and lifespan (Martens et al., 2018; Rajman et al., 2018; Yoshino et al., 2018). However, there are also some potential risks and limitations associated with these supplements. For example, some NAD+ precursors or intermediates may have side effects, such as flushing, nausea, or liver toxicity (Khan et al., 2019; Martens et al., 2018). Some may also interfere with other cellular pathways or processes that depend on NAD+, such as the activity of PARP enzymes or CD38 enzymes, which are involved in DNA repair and immune function, respectively (Chini et al., 2018; Mouchiroud et al., 2013). Moreover, the optimal dose, timing, frequency, and duration of supplementation are not well established for different populations and outcomes. Furthermore, the long-term safety and efficacy of these supplements in humans are not fully understood.
Therefore, while NAD+ boosting interventions may hold great promise for improving health and aging, there are still many gaps and challenges in the current evidence base. More rigorous and comprehensive research is needed to elucidate the mechanisms of action, pharmacokinetics, pharmacodynamics, interactions, and optimal protocols of these supplements in humans. Additionally, more reliable and standardized methods of measuring NAD+ levels and related biomarkers are needed to assess the effects of these supplements on cellular and organismal health. Finally, more personalized and targeted approaches are needed to identify the best candidates and conditions for these interventions.
References:
Bogan KL, Brenner C. Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition. Annu Rev Nutr. 2008;28:115-30.
Chini CC, Tarragó MG, Chini EN. NAD and the aging process: Role in life span regulation, senescence programing, caloric restriction response, cellular signaling, and mitochondrial functioning. Aging Cell. 2018;17(3):e12735.
Imai S, Guarente L. NAD +and sirtuins in aging and disease. Trends Cell Biol. 2014;24(8):464-71.
Khan NA, Auranen M, Paetau I, Pirinen E, Euro L, Forsström S, Pasila L, Velagapudi V, Carroll CJ, Auwerx J, Suomalainen A. Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3. EMBO Mol Med. 2014;6(6):721-31.
Martens CR, Denman BA, Mazzo MR, Armstrong ML, Reisdorph N, McQueen MB, Chonchol M, Seals DR. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD +in healthy middle-aged and older adults. Nat Commun. 2018;9(1):1286.
Mouchiroud L, Houtkooper RH, Moullan N, Katsyuba E, Ryu D are the authors of a scientific paper titled "Mitonuclear Protein Imbalance as a Conserved Longevity Mechanism". 2013

Comments
Post a Comment